Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Childs

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
Clinical Genitourinary Cancer|June 22, 2026
Longitudinal Tumor Mutation Burden Dynamics in Advanced Prostate Cancer Using Circulating Tumor DNA ProfilingNancy Wei, Jamie J O'Byrne, Miguel Muniz, et al.
Theranostics|April 22, 2024
Theranostics and artificial intelligence: new frontiers in personalized medicineGokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2013
HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancersMary L Disis, Yushe Dang, Andrew L Coveler, et al.
Molecular Cancer Therapeutics|March 6, 2008
Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunityVivian Goodell, James Waisman, Lupe G Salazar, et al.
BJUI Compass|February 19, 2024
Low PSA radiographic disease progression on C11-choline PETAhmed M Mahmoud, Mohamed E Ahmed, A Tuba Kendi, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 17, 2023
Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research RetreatAkeem R Lewis, Grace M Choong, Elizabeth Cathcart-Rake, et al.
Vaccines|February 26, 2025
A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast CancerWilliam R Gwin, Lupe G Salazar, James Y Dai, et al.
Clinical Genitourinary Cancer|November 2, 2025
Real-World Outcomes of Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma: A Multicenter Retrospective AnalysisPrateek Jain, Syed Arsalan Ahmed Naqvi, Nikita Tripathi, et al.
Journal of Translational Medicine|June 3, 2014
Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancerJianning Mao, Jon Ladd, Ekram Gad, et al.
JCO Oncology Practice|April 24, 2026
Efficacy and Safety of 177Lu-PSMA-617 in Elderly Patients With Metastatic Castration-Resistant Prostate CancerDaniel Sentana-Lledo, Avina Rami, Caiwei Zhong, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Clinical Genitourinary Cancer|June 22, 2026
Longitudinal Tumor Mutation Burden Dynamics in Advanced Prostate Cancer Using Circulating Tumor DNA ProfilingNancy Wei, Jamie J O'Byrne, Miguel Muniz, et al.
Theranostics|April 22, 2024
Theranostics and artificial intelligence: new frontiers in personalized medicineGokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2013
HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancersMary L Disis, Yushe Dang, Andrew L Coveler, et al.
Molecular Cancer Therapeutics|March 6, 2008
Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunityVivian Goodell, James Waisman, Lupe G Salazar, et al.
BJUI Compass|February 19, 2024
Low PSA radiographic disease progression on C11-choline PETAhmed M Mahmoud, Mohamed E Ahmed, A Tuba Kendi, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 17, 2023
Preparing Hematology/Oncology Fellows for Success: Implementing an Annual Career Development and Research RetreatAkeem R Lewis, Grace M Choong, Elizabeth Cathcart-Rake, et al.
Vaccines|February 26, 2025
A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast CancerWilliam R Gwin, Lupe G Salazar, James Y Dai, et al.
Clinical Genitourinary Cancer|November 2, 2025
Real-World Outcomes of Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma: A Multicenter Retrospective AnalysisPrateek Jain, Syed Arsalan Ahmed Naqvi, Nikita Tripathi, et al.
Journal of Translational Medicine|June 3, 2014
Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancerJianning Mao, Jon Ladd, Ekram Gad, et al.
JCO Oncology Practice|April 24, 2026
Efficacy and Safety of 177Lu-PSMA-617 in Elderly Patients With Metastatic Castration-Resistant Prostate CancerDaniel Sentana-Lledo, Avina Rami, Caiwei Zhong, et al.
Pageof 16